Moreover, one report suggests that HER2-positive cases are associated with a shorter period of time from G/GEJ cancer diagnosis to the emergence of brain metastases than HER2-negative cases23, and there is a similar report in breast cancer25. The gene discussed is ERBB2; the disease is cancer.